GS0421: Research and development in the pharmaceutical and biotechnology fields; pharmaceutical drug development services and pharmaceutical product evaluation services; providing services to others relating to analytical, chemistry and manufacturing controls for regulatory approval of small and large molecules drug products, namely, providing scientific information relating to the analysis and management of the drug manufacturing process for regulatory approval of small and large molecules drug products
Case File Event Statements
5/5/2020 - 4 years ago
29 - REGISTERED-PRINCIPAL REGISTERType:R.PR
3/28/2020 - 4 years ago
28 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILEDType:SUNA
3/27/2020 - 4 years ago
27 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTEDType:CNPR
3/16/2020 - 4 years ago
26 - STATEMENT OF USE PROCESSING COMPLETEType:SUPC
2/13/2020 - 4 years ago
25 - USE AMENDMENT FILEDType:IUAF
3/16/2020 - 4 years ago
24 - DIVISIONAL PROCESSING COMPLETEType:DPCC
2/13/2020 - 4 years ago
23 - DIVISIONAL REQUEST RECEIVEDType:DRRR
3/16/2020 - 4 years ago
22 - CASE ASSIGNED TO INTENT TO USE PARALEGALType:AITU
2/13/2020 - 4 years ago
21 - TEAS REQUEST TO DIVIDE RECEIVEDType:ERTD
2/13/2020 - 4 years ago
20 - TEAS STATEMENT OF USE RECEIVEDType:EISU
8/20/2019 - 4 years ago
19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANTType:NOAM
6/25/2019 - 5 years ago
18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
6/25/2019 - 5 years ago
17 - PUBLISHED FOR OPPOSITIONType:PUBO
6/5/2019 - 5 years ago
16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
5/16/2019 - 5 years ago
15 - ASSIGNED TO LIEType:ALIE
5/1/2019 - 5 years ago
14 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
4/8/2019 - 5 years ago
13 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
4/7/2019 - 5 years ago
12 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
4/7/2019 - 5 years ago
11 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA